During the past decade, Nemocnica Kosice-Saca, a.s.1.sukromna nemocnica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nemocnica Kosice-Saca, a.s.1.sukromna nemocnica" are "Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials), "Eczema" (1 trials), "Genetic Diseases, Inborn" (1 trials) and "Hypersensitivity" (1 trials). Many other conditions were trialed in "Nemocnica Kosice-Saca, a.s.1.sukromna nemocnica" in a lesser frequency.

Most popular intervention types in "Nemocnica Kosice-Saca, a.s.1.sukromna nemocnica" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dupilumab" (1 trials), "Injectable Placebo" (1 trials), "Oral Placebo" (1 trials), "PF-04965842 100 mg" (1 trials) and "PF-04965842 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnica Kosice-Saca, a.s.1.sukromna nemocnica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnica Kosice-Saca, a.s.1.sukromna nemocnica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nemocnica Kosice-Saca, a.s.1.sukromna nemocnica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnica Kosice-Saca, a.s.1.sukromna nemocnica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".